Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl.
Jun YangZhuqing RaoFu HongVatche AgopianJennifer Nguyen-LeeRandolph H SteadmanChristopher WrayVictor W XiaPublished in: Clinical transplantation (2021)
Takotsubo syndrome (TTS) can develop after liver transplant (LT), but its predisposing factors are poorly understood. In this study, we aimed to determine if perioperative factors were associated with posttransplant TTS. Adult patients who underwent primary LT between 2006 and 2018 were included. Patients with and without TTS were identified and matched by propensity scores. Of 2181 LT patients, 38 developed postoperative TTS with a mean left ventricular ejection fraction of 25.5% (±7.8%). Multivariable logistic regression revealed two preoperative risk factors (alcoholic cirrhosis and model for end-stage liver disease-sodium scores) for TTS. Post-propensity match analyses showed that TTS patients had significantly higher doses of epinephrine and lower doses of fentanyl during LT compared with non-TTS patients. A higher dose of epinephrine and a lower dose of fentanyl was associated with a higher predicted probability of TTS. All TTS patients had full recovery of cardiac function and had comparable 1-year survival. In conclusion, TTS occurred at a rate of 1.7% after LT and was associated with two pretransplant risk factors. The higher doses of epinephrine and lower doses of fentanyl administered during LT were associated with posttransplant TTS. More studies on the relationship between intraoperative medications and TTS are warranted.
Keyphrases
- ejection fraction
- end stage renal disease
- risk factors
- newly diagnosed
- chronic kidney disease
- aortic stenosis
- left ventricular
- patients undergoing
- peritoneal dialysis
- heart failure
- coronary artery disease
- acute myocardial infarction
- single cell
- case report
- percutaneous coronary intervention
- cardiac resynchronization therapy